Table II:
Outcomes, Clinical Complications, and COVID-19 Interventions
| NHW na (%) |
Black na (%) |
Hispanic na (%) |
AAPI na (%) |
Other na (%) |
All na (%) |
|
|---|---|---|---|---|---|---|
| Outcomes | ||||||
| Total all-cause mortalityb | 60 (8) | 38 (13) | 12 (5) | <5(<11) | 9 (12) | 123 (9) |
| 30-day all-cause mortalityc | 40 (5) | 29 (10) | 8 (3) | <5 (<11) | 8 (10) | 89 (6) |
| Received mechanical ventilationb | 24 (3) | 26 (9) | 11 (5) | <5 (<11) | <5 (<6) | 69 (5) |
| Admitted to an intensive care unitb | 45 (6) | 31 (11) | 18 (8) | 7 (16) | 10 (13) | 111 (8) |
| Admitted to the hospitalb | 245 (33) | 137 (47) | 77 (33) | 20 (44) | 33 (42) | 512 (37) |
| Clinical complications | ||||||
| Any cardiovascular complicationd | 82 (11) | 50 (17) | 30 (13) | 6 (13) | 18 (23) | 186 (14) |
| Any pulmonary complicatione | 170 (23) | 88 (31) | 43 (18) | 12 (27) | 23 (30) | 336 (24) |
| Any gastrointestinal complicationf | 12 (2) | 7 (2) | <5 (<2) | <5 (<11) | <5 (<7) | 26 (2) |
| Acute kidney injury | 41 (6) | 46 (16) | 11 (5) | 5 (11) | 10 (13) | 113 (8) |
| Multisystem organ failure | 10 (1) | 12 (4) | <5 (<2) | <5 (<11) | <5 (<7) | 29 (2) |
| Superimposed infection | 62 (9) | 42 (15) | 14 (6) | 7 (16) | <5 (<7) | 129 (10) |
| Sepsis | 43 (6) | 24 (8) | 15 (6) | 7 (16) | 12 (16) | 101 (7) |
| Any bleeding | 15 (2) | 7 (2) | <5 (<2) | <5 (<11) | <5 (<7) | 29 (2) |
| Interventions | ||||||
| Remdesivir | 68 (10) | 20 (7) | 15 (7) | 8 (18) | 5 (7) | 116 (9) |
| Hydroxychloroquine | 60 (9) | 41 (15) | 14 (6) | <5 (<11) | 11 (15) | 129 (10) |
| Systemic Corticosteroids | 107 (15) | 50 (18) | 31 (14) | 8 (18) | 13 (18) | 209 (16) |
| Other | 112 (16) | 53 (19) | 36 (16) | 11 (25) | 12 (17) | 224 (17) |
| Supplemental oxygen | 173 (24) | 87 (31) | 43 (19) | 14 (31) | 24 (31) | 341 (25) |
Variable categories with one to five cases are masked by replacing with N < 5 according to CCC19 policy
N based on number of patients with non-missing data.
Included in primary outcome
Secondary outcome
Cardiovascular complication includes hypotension, myocardial infarction, other cardiac ischemia, atrial fibrillation, ventricular fibrillation, other cardiac arrhythmia, cardiomyopathy, congestive heart failure, pulmonary embolism (PE), deep vein thrombosis (DVT), stroke, thrombosis NOS complication.
Pulmonary complication includes respiratory failure, pneumonitis, pneumonia, acute respiratory distress syndrome (ARDS), PE, pleural effusion, empyema.
Gastrointestinal complication includes acute hepatic injury, ascites, bowel obstruction, bowel perforation, ileus, peritonitis